Vaccines for Immune Mediated Diseases

Patients with immune-mediated inflammatory diseases (IMID) such as RA, IBD or psoriasis, are at increased risk of infection, partially because of the disease itself, but mostly because of treatment with immune-modulatory or immunosuppressive drugs. In spite of their elevated risk for vaccine-preventable disease, vaccination coverage in IMID patients is surprisingly low. Although the reduced quality of the immune response in patients under immunotherapy may have a negative impact on vaccination efficacy in this population, adequate humoral response to vaccination in IMID patients has been demonstrated for Hepatitis B, Influenza and Pneumococcal vaccination

 

    Related Conference of Vaccines for Immune Mediated Diseases

    June 04-05, 2026

    30th World Nutrition and Pediatrics Healthcare Conference

    Zurich, Switzerland
    June 11-12, 2026

    27th Annual World Congress on Pediatrics

    Barcelona, Spain
    June 22-23, 2026

    35th World Congress on Clinical Pediatrics

    Barcelona, Spain
    June 29-30, 2026

    6th Global Summit on Pediatric Nursing

    Barcelona, Spain
    July 27-28, 2026

    3rd World Pediatric Conference

    London, UK
    August 18-19, 2026

    8th World Pediatric Infectious Disease Congress

    Paris, France
    September 07-08, 2026

    24rd World Congress on Clinical Pediatrics

    Toronto, Canada
    September 14-15, 2026

    26th Annual Congress on Pediatrics & Neonatology

    Rome, Italy
    November 19-20, 2026

    37th European Pediatrics Conference

    Dubai, UAE

    Vaccines for Immune Mediated Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in